Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 2
2012 2
2014 1
2017 2
2018 1
2019 2
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Functional testicular evaluation using PET/CT with 18F-fluorodeoxyglucose.
Dierickx LO, Huyghe E, Nogueira D, Zerdoud S, Filleron T, Brillouet S, Delauney B, Montagut J, Bujan L, Plante P, Courbon F. Dierickx LO, et al. Among authors: brillouet s. Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):129-37. doi: 10.1007/s00259-011-1929-3. Epub 2011 Sep 10. Eur J Nucl Med Mol Imaging. 2012. PMID: 21909754
The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells.
Bauriaud-Mallet M, Vija-Racaru L, Brillouet S, Mallinger A, de Medina P, Rives A, Payre B, Poirot M, Courbon F, Silvente-Poirot S. Bauriaud-Mallet M, et al. Among authors: brillouet s. J Steroid Biochem Mol Biol. 2019 Sep;192:105390. doi: 10.1016/j.jsbmb.2019.105390. Epub 2019 Jun 3. J Steroid Biochem Mol Biol. 2019. PMID: 31170473
Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.
Vija Racaru L, Sinigaglia M, Kanoun S, Ben Bouallègue F, Tal I, Brillouet S, Bauriaud-Mallet M, Zerdoud S, Dierickx L, Vallot D, Caselles O, Gabiache E, Pascal P, Courbon F. Vija Racaru L, et al. Among authors: brillouet s. Nucl Med Commun. 2018 Jul;39(7):672-679. doi: 10.1097/MNM.0000000000000850. Nucl Med Commun. 2018. PMID: 29790867 Free PMC article.
Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: real life experience and predictive factors of functional response.
Vija Racaru L, Fontan C, Bauriaud-Mallet M, Brillouet S, Caselles O, Zerdoud S, Bastié D, Vallot D, Caron P, Bardiès M, Courbon F. Vija Racaru L, et al. Among authors: brillouet s. Nucl Med Commun. 2017 Sep;38(9):756-763. doi: 10.1097/MNM.0000000000000705. Nucl Med Commun. 2017. PMID: 28719405 Clinical Trial.
11 results